FERRIPROX
Identification of Ferriprox
| No description |
Google image searchProduct monograph
Active ingredient
deferiprone, 500 MG
DIN: 02436531
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: CHIESI CANADA CORP.
Date: 12-MAR-2020
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AC — Iron chelating agents (ATC, ATC/DDD)
- V03AC02 — DEFERIPRONE (ATC/DDD)
Pharmaceutical standard: PH EUR
